Sciegen Pharmaceuticals India Profile
Key Indicators
- Authorised Capital ₹ 9.00 Cr
as on 04-10-2024
- Paid Up Capital ₹ 8.57 M
as on 04-10-2024
- Company Age 11 Year, 10 Months
- Last Filing with ROC 31 Mar 2023
- Revenue 15.55%
(FY 2023)
- Profit -74.73%
(FY 2023)
- Ebitda -14.69%
(FY 2023)
- Net Worth 276.67%
(FY 2023)
- Total Assets 204.22%
(FY 2023)
About Sciegen Pharmaceuticals India
The Corporate was formerly known as Pmr Energy Private Limited. The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 9.00 Cr and a paid-up capital of Rs 8.57 M, as per Ministry of Corporate Affairs (MCA) records.
Alla Reddy, Pailla Reddy, Venkata Pallempalli, and One other member serve as directors at the Company.
- CIN/LLPIN
U24240TG2013PTC085471
- Company No.
085471
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
28 Jan 2013
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Hyderabad
Industry
Company Details
- Location
Hyderabad, Telangana, India
- Telephone
- Email Address
- Website
- Social Media
Who are the key members and board of directors at Sciegen Pharmaceuticals India?
Board Members(4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Alla Reddy  | Director | 02-Oct-2017 | Current |
Pailla Reddy  | Director | 28-Dec-2015 | Current |
| Venkata Pallempalli | Director | 10-Aug-2018 | Current |
| Saketh Pailla | Director | 29-Apr-2023 | Current |
Financial Performance and Corporate Structure Insights of Sciegen Pharmaceuticals India.
Sciegen Pharmaceuticals India Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 15.55% increase. The company also saw a substantial fall in profitability, with a 74.73% decrease in profit. The company's net worth Soared by an impressive increase of 276.67%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Sciegen Pharmaceuticals India?
Unlock access to Sciegen Pharmaceuticals India's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Smart Agro Industries Corporation Private LimitedActive 15 years 10 monthsSaketh Pailla is a mutual person
Smart Agro Food Park Private LimitedActive 10 years 6 monthsPailla Reddy and Saketh Pailla are mutual person
Chemeca Drugs Private LimitedActive 21 years 2 monthsAlla Reddy, Pailla Reddy and 2 more are mutual person
Bactolac Nutraceuticals Private LimitedActive 1 year 5 monthsAlla Reddy, Pailla Reddy and 1 more are mutual person
- Azura Plastics Private LimitedActive 1 year 5 months
Alla Reddy, Pailla Reddy and 1 more are mutual person
- Chemart Pharma Private LimitedActive 4 years 4 months
Alla Reddy and Saketh Pailla are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Sciegen Pharmaceuticals India?
Sciegen Pharmaceuticals India has a workforce of 45 employees as of Oct 03, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Sciegen Pharmaceuticals India, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Sciegen Pharmaceuticals India's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
